Melguizo Alonso, Consolación Author
Formulation and in vitro evaluation of magnetoliposomes as a potential nanotool in colorectal cancer therapy
- Lorente C.
- Cabeza L.
- Clares B.
- Ortiz R.
- Halbaut L.
- Delgado Á.
- Perazzoli G.
- Prados J.
- Arias J.
- Melguizo C.
COLLOIDS AND SURFACES B-BIOINTERFACES - 1/11/2018
10.1016/j.colsurfb.2018.07.070
- SJR Quartile: Q1
- JCR Impact Factor: 3.973 (2018)
- CiteScore: 8.2 (2020)
- SJR: 0.957 (2018
- SNIP: 1.065 (2018
- JCR 5-year Impact Factor: 4.18
- JCR Categories: MATERIALS SCIENCE, BIOMATERIALS
- SJR Categories: Medicine (miscellaneous) (Q1); Surfaces and Interfaces (Q1); Biotechnology (Q2); Colloid and Surface Chemistry (Q2); Physical and Theoretical Chemistry (Q2)
- Scopus
- ORCID
- Web of Science
In vitro evidence of the antitumor capacity of Solanaceae and Cucurbitaceae in colon cancer: A systematic review
- Mesas C.
- Fuel M.
- Martínez R.
- Prados J.
- Melguizo C.
- Porres J.M.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION - 1/1/2021
- JCR Quartile: Q2 (2021)
- JCR Impact Factor: 11.208 (2022)
- Category normalized Impact: 0.299 (2021)
- CiteScore: 20.8 (2021)
- SJR: 1.749 (2021
- SNIP: 2.829 (2021
- JCR 5-year Impact Factor: 12.104
- JCR Categories: FOOD SCIENCE & TECHNOLOGY
- Scopus
- ORCID
- Web of Science
Last advances in nanocarriers-based drug delivery systems for colorectal cancer
- Rama A.
- Jimenez-Lopez J.
- Cabeza L.
- Jimenez-Luna C.
- Leiva M.
- Perazzoli G.
- Hernandez R.
- Zafra I.
- Ortiz R.
- Melguizo C.
- Prados J.
Current Drug Delivery - 1/9/2016
10.2174/1567201813666151203232852
- SJR Quartile: Q2
- JCR Impact Factor: 2.516 (2016)
- CiteScore: 3.6 (2020)
- SJR: 0.504 (2016
- SNIP: 0.747 (2016
- JCR 5-year Impact Factor: 2.338
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Pharmaceutical Science (Q2)
- Scopus
- ORCID
- Web of Science
Nanomedicine in Pancreatic Cancer: A New Hope for Treatment
- Redruello P.
- Perazzoli G.
- Cepero A.
- Quiñonero F.
- Mesas C.
- Doello K.
- Láinez-Ramos-bossini A.
- Rivera-Izquierdo M.
- Melguizo C.
- Prados J.
Current Drug Targets - 27/11/2020
10.2174/1389450121666200703195229
- JCR Quartile: Q2 (2020)
- JCR Impact Factor: 3.465 (2023)
- Category normalized Impact: 0.146 (2020)
- CiteScore: 5.6 (2020)
- SJR: 0.826 (2020
- SNIP: 0.909 (2020
- JCR 5-year Impact Factor: 3.758
- JCR Categories: PHARMACOLOGY & PHARMACY
- Scopus
- ORCID
- Web of Science
How is gene transfection able to improve current chemotherapy? The role of combined therapy in cancer treatment
- Prados J.
- Álvarez P.J.
- Melguizo C.
- Rodriguez-Serrano F.
- Carrillo E.
- Boulaiz H.
- Vélez C.
- Marchal J.A.
- Caba O.
- Ortiz R.
- Rama A.
- Aranega A.
Current Medicinal Chemistry - 1/4/2012
- JCR Quartile: Q4 (2012)
- SJR Quartile: Q1
- JCR Impact Factor: 4.07 (2012)
- Category normalized Impact: 0.169 (2012)
- CiteScore: 6.9 (2020)
- SJR: 1.538 (2012
- SNIP: 1.429 (2012
- JCR 5-year Impact Factor: 4.471
- JCR Categories: CHEMISTRY, MEDICINAL
- SJR Categories: Pharmacology (Q1); Molecular Medicine (Q2)
- Scopus
- ORCID
- Web of Science
Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications
- Ortiz R.
- Perazzoli G.
- Cabeza L.
- Jiménez-Luna C.
- Luque R.
- Prados J.
- Melguizo C.
Current Neuropharmacology - 1/1/2021
10.2174/1570159x18666200626204005
- JCR Quartile: Q1 (2021)
- JCR Impact Factor: 7.708 (2023)
- Category normalized Impact: 2.7 (2021)
- CiteScore: 10.5 (2020)
- SJR: 1.955 (2020
- SNIP: 1.851 (2020
- JCR 5-year Impact Factor: 9.589
- JCR Categories: NEUROSCIENCES
- Scopus
- ORCID
- Web of Science
Transcriptional profiling of peripheral blood in pancreatic adenocarcinoma patients identifies diagnostic biomarkers
- Caba, Octavio
- Prados, Jose
- Ortiz, Raul
- Jimenez-Luna, Cristina
- Melguizo, Consolacion
- Alvarez, Pablo J.
- Delgado, Juan R.
- Irigoyen, Antonio
- Rojas, Ignacio
- Perez-Florido, Javier
- Torres, Carolina
- Perales, Sonia
- Linares, Ana
- Aranega, Antonia
Digestive diseases and sciences - 18/11/2014
- SJR Quartile: Q2
- JCR Impact Factor: 2.613 (2014)
- CiteScore: 5.2 (2020)
- SJR: 1.076 (2014
- SNIP: 0.972 (2014
- JCR 5-year Impact Factor: 2.495
- JCR Categories: GASTROENTEROLOGY & HEPATOLOGY
- SJR Categories: Gastroenterology (Q2); Physiology (Q2)
- Scopus
- ORCID
- Web of Science
Tissue Specific Promoters in Colorectal Cancer
- Rama A.R.
- Aguilera A.
- Melguizo C.
- Caba O.
- Prados J.
DISEASE MARKERS - 1/1/2015
- SJR Quartile: Q2
- JCR Impact Factor: 2.137 (2015)
- CiteScore: 4.1 (2020)
- SJR: 0.805 (2015
- SNIP: 0.725 (2015
- JCR 5-year Impact Factor: 2.16
- JCR Categories: BIOTECHNOLOGY & APPLIED MICROBIOLOGY
- SJR Categories: Biochemistry (medical) (Q2); Clinical Biochemistry (Q2); Medicine (miscellaneous) (Q2); Genetics (Q3); Molecular Biology (Q3)
- Scopus
- ORCID
- Web of Science
Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(Butylcyanoacrylate) nanoparticles
Drug Design Development and Therapy - 14/12/2015
- SJR Quartile: Q1
- JCR Impact Factor: 2.881 (2015)
- CiteScore: 3.27 (2018)
- SJR: 0.982 (2015
- SNIP: 0.978 (2015
- JCR 5-year Impact Factor: 2.962
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)
- Scopus
- ORCID
- Web of Science
Evaluation of cytotoxic effect of siphonochilone from African ginger: an in vitro analysis
- Ortigosa-Palomo A.
- Fuentes-Ríos D.
- Quiñonero F.
- Melguizo C.
- Ortiz R.
- López-Romero J.M.
- Prados J.
Environmental Toxicology - 1/1/2024
- CiteScore: 7.1 (2023)
- SJR: 0.921 (2023
- SNIP: 0.852 (2023
The story of a doctoral thesis: GEF, a new gene with applications in anti-tumor gene therapy
- Boulaiz, H
- Prados, J
- Melguizo, C
- Marchal, JA
- Carrillo, E
- Velez, C
- Fernandez, JE
- Alvarez, L
- Caba, O
- Aranega, A
CELLULAR AND MOLECULAR BIOLOGY - 06/2003
- JCR Quartile: Q4 (2003)
- SJR Quartile: Q1
- JCR Impact Factor: 1.153 (2022)
- SJR Categories: Medicine (miscellaneous) (Q1)
Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy
- Marchal J.
- García M.
- Boulaiz H.
- Perán M.
- Álvarez P.
- Prados J.
- Melguizo C.
- Aránega A.
Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 - 1/1/2012
- Scopus
- ORCID
This author has no conferences.
This author has no patents.
Downregulated microRNAs in the colorectal cancer: Diagnostic and therapeutic perspectives
- Hernández R.
- Sánchez-Jiménez E.
- Melguizo C.
- Prados J.
- Rama A.R.
BMB Reports - 1/1/2018
- SJR Quartile: Q1
- JCR Impact Factor: 2.966 (2018)
- CiteScore: 6 (2020)
- SJR: 1.082 (2018
- SNIP: 0.952 (2018
- JCR 5-year Impact Factor: 2.838
- JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
- SJR Categories: Medicine (miscellaneous) (Q1); Biochemistry (Q2); Molecular Biology (Q2)
- Scopus
- ORCID
- Web of Science
Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)
- Ballesteros A.
- Hernández R.
- Perazzoli G.
- Cabeza L.
- Melguizo C.
- Vélez C.
- Prados J.
CANCER GENE THERAPY - 1/1/2020
- JCR Impact Factor: 5.987 (2020)
- CiteScore: 8.1 (2020)
- SJR: 1.535 (2020
- SNIP: 1.113 (2020
- JCR 5-year Impact Factor: 5.358
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Synthesis, solubility and antitumor activity of maslinic acid derivatives
- Fuentes-Rios, D.
- Cepero, A.
- Garcia-Castro, M.
- Contreras-Caceres, R.
- Lopez-Romero, J. M.
- Luque, C.
- Cabeza, L.
- Melguizo, C.
- Prados, J.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS - 4/2022
Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review
- Lidia Gago
- Francisco Quiñonero
- Gloria Perazzoli
- Consolacion Melguizo
- Jose Prados
- Raul Ortiz
- Laura Cabeza
Pharmaceutics - 13/06/2023
- Scopus
- ORCID
- Web of Science
Contact info
Email: melguizo@ual.es
h index
Scopus: 27
Web of Science: 30
i10 index
Scopus: 78
Web of Science: 90
Author profiles
-
ORCID
-
Web of Science ResearcherID
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym CV20-78799Since: September 8, 2020Until: September 7, 2021Funded by: JUNTAFunding / grant amount: 60,000.00 EURRole: Investigador